Approval · Notice of Compliance 2556 · 2001
ACID REDUCER: Notice of Compliance 2556
Issued March 6, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2556
- Date
- March 6, 2001
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Product name change from peptic relief
- Therapeutic class
- Histamine H2-receptor antagonist
- Canadian reference product
- ZANTAC (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACID REDUCER | 02237829 | Cancelled Post Market |
Medicinal ingredients
- RANITIDINE HCL 84 MG per TAB